Showing results (171-180 of 631) with videos related to
Sort By:
Pageof 64
Journal of Cardiovascular Pharmacology|June 1, 1996
Comparative antigenicity of recombinant wild-type staphylokinase (SakSTAR) and a selected mutant (SakSTAR.M38) in a baboon thrombolysis modelS Vanderschueren, J M Stassen, D CollenThrombosis Research|June 1, 1984
Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketonesH R Lijnen, M Uytterhoeven, D CollenThe Journal of Clinical Investigation|August 1, 1971
Metabolism of fibrinogen in cirrhosis of the liverG N Tytgat, D Collen, M VerstraeteThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis modelY Imura, J M Stassen, D CollenThe Journal of Biological Chemistry|October 5, 1985
A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivoP Holvoet, H R Lijnen, D CollenThe Journal of Biological Chemistry|May 5, 1993
Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasminK Silence, D Collen, H R LijnenThrombosis and Haemostasis|October 1, 1981
Turnover of human extrinsic (tissue-type) plasminogen activator in rabbitsC Korninger, J M Stassen, D CollenCirculation Research|December 11, 1999
Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in miceH R Lijnen, P Soloway, D CollenEuropean Journal of Biochemistry|July 1, 1985
Characterization of the high-affinity interaction between human plasminogen and pro-urokinaseH R Lijnen, C Zamarron, D CollenPageof 64